StonvexLoading…
StonvexStonvexStonvexCore line items from SGHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | €1.70B | €1.44B | €1.29B | €1.32B |
Operating Income | €188.80M | €16.78M | €216.51M | €225.91M |
Net Income | €113.55M | €-8.61M | €182.27M | €235.88M |
EPS (Diluted) | €0.22 | €-0.02 | €0.37 | €0.50 |
Total Assets | €1.05B | €960.87M | €877.00M | €844.07M |
Total Liabilities | €497.04M | €422.08M | €342.35M | €330.02M |
Cash & Equivalents | €372.88M | €241.92M | €254.78M | €293.80M |
Free Cash Flow OCF − CapEx | €271.42M | €123.74M | €160.53M | €206.71M |
Shares Outstanding | 0 | 0 | 31.48M | 25.45M |